About Docturnal
Docturnal is a company based in Hyderabad (India) founded in 2016 by Arpita Singh. Docturnal has raised $92.31 thousand across 4 funding rounds from investors including Mumbai Angels, Axilor Ventures and CIE IIITH. Docturnal offers products and services including TimBre, Pneumonia Solution, and COPD/Asthma Solution. Docturnal operates in a competitive market with competitors including ResApp Health, Medsensio, Tambua Health, RESPINOR and Ibrum Technologies, among others.
- Headquarter Hyderabad, India
- Founders Arpita Singh
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Docturnal Private Limited
- Date of Incorporation 29 Apr, 2016
- Jurisdiction Secunderabad, Telangana, India
-
Annual Revenue
$25.74 K (USD)-13.44as on Mar 31, 2021
-
Net Profit
-$17.56 K (USD)67.21as on Mar 31, 2021
-
EBITDA
-$16.33 K (USD)79.8as on Mar 31, 2021
-
Total Equity Funding
$92.31 K (USD)
in 4 rounds
-
Latest Funding Round
$21.59 K (USD), Seed
Oct 16, 2019
-
Investors
Mumbai Angels
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Docturnal
Docturnal offers a comprehensive portfolio of products and services, including TimBre, Pneumonia Solution, and COPD/Asthma Solution.
Acoustic-based tool for pulmonary TB detection in 20 seconds
Acoustic system for detecting pneumonia and other ailments
Device for screening chronic respiratory conditions
People of Docturnal
Unlock access to complete
Data Analysis and Operations Team
1 people
Software Development Team
1 people
Leadership Team
1 people
Unlock access to complete
Funding Insights of Docturnal
Docturnal has successfully raised a total of $92.31K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $21.59 thousand completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Docturnal
Docturnal has secured backing from 15 investors, including angel and venture fund investors. Prominent investors backing the company include Mumbai Angels, Axilor Ventures and CIE IIITH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Incubation and management consulting services are provided for start-ups and emerging businesses across various sectors.
|
Locked | Locked | Locked | |
|
Early-stage venture investments are facilitated by Mumbai Angels network.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early-stage startups in technology sectors.
|
Locked | Locked | Locked |
Investor details for Docturnal
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Docturnal
Investment portfolio details for Docturnal
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Docturnal
Detailed financials for Docturnal
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Docturnal Comparisons
Peer comparison for Docturnal
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Docturnal
Docturnal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ResApp Health, Medsensio, Tambua Health, RESPINOR and Ibrum Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Respiratory diseases are diagnosed digitally from cough and breathing sounds.
|
|
| Locked | Locked | Locked |
Respiratory diagnostics are enhanced via a deep learning platform.
|
|
| Locked | Locked | Locked |
Software for sound based cardiopulmonary disease diagnosis
|
|
| Locked | Locked | Locked |
Real-time diaphragm monitoring devices are provided for medical decision making.
|
|
| Locked | Locked | Locked |
Devices for detecting undiagnosed cardiac and respiratory diseases are developed.
|
Detailed competitors of Docturnal
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Docturnal
Complete news archive for Docturnal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Docturnal
Docturnal was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Docturnal is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Docturnal is a funded company, having raised a total of $92.31K across 4 funding rounds to date.
Annual revenue of Docturnal is $25.74K as on Mar 31, 2021.
Docturnal was founded in 2016 in Hyderabad, India, and operates in the health technology sector. Non-invasive tools for tuberculosis detection, care screening, and diagnostics are developed, including the TimBre app, which analyzes cough sounds recorded by healthcare providers for real-time assessment. Additional solutions for COPD and asthma identification through acoustic analysis are also offered, focusing on aural components for respiratory conditions.
Docturnal offers TimBre, Pneumonia Solution, and COPD/Asthma Solution.
Docturnal has 15 investors. Key investors include Mumbai Angels, Axilor Ventures, CIE IIITH, Purple Ventures, and Abhijeet Birewar.
The valuation of Docturnal is $636.97K as of Oct 2019.